If side effects are intolerable at a new dose, the standard approach is to drop back to the previous dose for 2 more weeks before attempting the increase again
In-depth review of the hitherto proposed mechanisms involved in diabetes-related glomerular hyperfiltration, its clinical significance and available and emerging interventions that might attenuate this renal haemodynamic abnormality
Glucagon-like peptide-1 receptor agonists were linked to a significantly higher risk for aspiration pneumonia after gastrointestinal endoscopy, particularly among those undergoing upper endoscopy and propofol sedation, according to a study
Learning where to inject, such as the abdomen, thigh, or upper arm, and choosing a consistent day each week can help you stay on track
These findings underscore the multifaceted nature of GLP-1 receptor agonists in cardiovascular risk reduction and have profound implications for the treatment of different profiles of T2D patients